dfcomb: An R-package for phase I/II trials of drug combinations

被引：2
|
作者：
Riviere, Marie-Karelle [1 ]
Jourdan, Jacques-Henri [2 ]
Zohar, Sarah [1 ]
机构：
[1] Univ Paris 06, INSERM, U1138, Univ Paris 05,Equipe 22,Ctr Rech Cordeliers, Paris, France
[2] INRIA Paris Rocquencourt, Paris, France
来源：
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE | 2016年 / 125卷
关键词：
Dose-finding; Phase I; Combination; Adaptive design; R package; DOSE-FINDING DESIGN; AGENT;
D O I：
10.1016/j.cmpb.2015.10.018
中图分类号：
TP39 [计算机的应用];
学科分类号：
081203 ; 0835 ;
摘要：
In this paper, we present the dfcomb R package for the implementation of a single prospective clinical trial or simulation studies of phase I combination trials in oncology. The aim is to present the features of the package and to illustrate how to use it in practice though different examples. The use of combination clinical trials is growing, but the implementation of existing model-based methods is complex, so this package should promote the use of innovative adaptive designs for early phases combination trials. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：117 / 133
页数：17
相关论文
共 50 条
  • [1] pocrm: An R-package for Phase I trials of combinations of agents
    Wages, Nolan A.
    Varhegyi, Nikole
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2013, 112 (01) : 211 - 218
  • [2] dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials
    Toumazi, A.
    Comets, E.
    Alberti, C.
    Friede, T.
    Lentz, F.
    Stallard, N.
    Zohar, S.
    Ursino, M.
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2018, 157 : 163 - 177
  • [3] Phase II trials of drug combinations: fairytales or fact?
    Verweij, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (02) : 195 - 196
  • [4] Bayesian procedures for phase I/II clinical trials investigating the safety and efficacy of drug combinations
    Whitehead, John
    Thygesen, Helene
    Whitehead, Anne
    [J]. STATISTICS IN MEDICINE, 2011, 30 (16) : 1952 - 1970
  • [5] A Bayesian hierarchal modeling approach to shortening phase I/II trials of anticancer drug combinations
    Yada, Shinjo
    Hamada, Chikuma
    [J]. PHARMACEUTICAL STATISTICS, 2018, 17 (06) : 750 - 760
  • [6] DNABarcodeCompatibility: an R-package for optimizing DNA-barcode combinations in multiplex sequencing experiments
    Trebeau, Celine
    de Monvel, Jacques Boutet
    Tai, Fabienne Wong Jun
    Petit, Christine
    Etournay, Raphael
    [J]. BIOINFORMATICS, 2019, 35 (15) : 2690 - 2691
  • [7] Visualizing adverse events in clinical trials using correspondence analysis with R-package visae
    Diniz, Marcio A.
    Gresham, Gillian
    Kim, Sungjin
    Luu, Michael
    Henry, N. Lynn
    Tighiouart, Mourad
    Yothers, Greg
    Ganz, Patricia A.
    Rogatko, Andre
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
  • [8] NCC: An R-package for analysis and simulation of platform trials with non-concurrent controls
    Krotka, Pavla
    Hees, Katharina
    Jacko, Peter
    Magirr, Dominic
    Posch, Martin
    Roig, Marta Bofill
    [J]. SOFTWAREX, 2023, 23
  • [9] Visualizing adverse events in clinical trials using correspondence analysis with R-package visae
    Márcio A. Diniz
    Gillian Gresham
    Sungjin Kim
    Michael Luu
    N. Lynn Henry
    Mourad Tighiouart
    Greg Yothers
    Patricia A. Ganz
    André Rogatko
    [J]. BMC Medical Research Methodology, 21
  • [10] A Bayesian seamless phase I-II trial design with two stages for cancer clinical trials with drug combinations
    Jimenez, Jose L.
    Kim, Sungjin
    Tighiouart, Mourad
    [J]. BIOMETRICAL JOURNAL, 2020, 62 (05) : 1300 - 1314
12345